Niraparib + Niraparib Tosilate Monohydrate

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Niraparib niraparib
Niraparib Tosilate Monohydrate niraparib-tosilate-monohydrate

Brands with this exact combination

Brand	Composition & strength	Manufacturer
ZEJULAAU CA ES EU GB HK SG TW US	tablet ×13 Niraparib 100 mg unknown ×3 Niraparib tablet ×2 Niraparib 200 mg tablet Niraparib 300 mg Other 1 compositions	GlaxoSmithKline LLC

Brand

Composition & strength

Manufacturer

ZEJULAAU CA ES EU GB HK SG TW US

tablet ×13 Niraparib 100 mg
unknown ×3 Niraparib
tablet ×2 Niraparib 200 mg
tablet Niraparib 300 mg

Other 1 compositions

GlaxoSmithKline LLC

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.